Abstract
Background
Malignant giant-cell tumors (MGCT) comprise 2–9% of all giant-cell tumors (GCTs). The limited existing studies fail to distinguish primary, secondary, or postradiation cancers, making it difficult to design rational treatment strategies. This study compared malignant to benign GCTs and defined the clinical outcome of the patients in a large series of case-matched patients from a single institution.
Methods
Clinical, radiological, and outcome features were compared between 26 malignant and 244 benign GCTs treated in our institution. Five postradiation cancers were excluded. We also performed a 1:2 case-matched comparison of patients with malignant and benign disease.
Results
Distal femur (P = 0.019), proximal tibia (P = 0.032), and distal tibia (P = 0.049) had a higher frequency of MGCT. Campanacci stage 1 tumors had a low probability of malignancy (P = 0.017). MGCT were less likely to have aneurysmal bone cyst changes. The 5-year recurrence-free status probability was 80% for malignant and 91% for benign cases in matched groups. The difference in the recurrence rate between benign and malignant groups was not statistically significant (P = 0.24). Functional impairment and limited activity were greater in MGCT patients than in benign GCT patients, whether treated by resection/amputation or curettage/cryosurgery.
Conclusions
We found that malignant and benign GCT have similar epidemiology and that recurrence was higher in MGCT (20 v 9%). Local recurrence for MGCT was not statistically different for excision versus intralesional therapy, but there was little statistical power. Finally, the 16% mortality for patients with MGCT suggests low-grade malignancy.
Similar content being viewed by others
References
Jaffe HL, Lichtenstein L, Portis RB. Giant cell tumor of bone. Its pathologic appearance, grading, supposed variants and treatment. Arch Pathol. 1940;30:993–1031.
Hutter RV, Worcester JN Jr, Francis KS, Foote FW Jr, Stewart FW. Benign and malignant giant cell tumors of bone. A clinicopathological analysis of the natural history of the disease. Cancer. 1962;15:653–90.
Unni KK. Classification of bone tumours. Can J Surg. 1977;20:504–9.
Rock MG, Sim FH, Unni KK, et al. Secondary malignant giant-cell tumor of bone. Clinicopathological assessment of nineteen patients. J Bone Joint Surg. 1986;68A:1073–9.
Bertoni F, Bacchini P, Staals EL. Malignancy in giant cell tumor of bone. Cancer. 2003;97:2520–9.
Dahlin DC, Cupps RE, Johnson EW Jr. Giant-cell tumor: a study of 195 cases. Cancer. 1970;25:1061–70.
Anract P, De Pinieux G, Cottias P, et al. Malignant giant-cell tumours of bone. Clinico-pathological types and prognosis: a review of 29 cases. Int Orthop. 1998;22:19–26.
Nascimento AG, Huvos AG, Marcove RC. Primary malignant giant cell tumor of bone: a study of eight cases and review of the literature. Cancer. 1979;44:1393–402.
Carrasco CH, Murray JA. Giant cell tumors. Orthop Clin North Am. 1989;20:395–405.
Huvos AG. Bone tumors: diagnosis, treatment, and prognosis. 2nd ed. Philadelphia: WB Saunders, 1991.
Campanacci M, Baldini N, Boriani S, Sudanese A. Giant-cell tumor of bone. J Bone Joint Surg. 1987;69A:106–114.
Imsamran W, Leelawat K, Leelawat T, et al. Simple technique in the measurement of liver volume. J Med Assoc Thai. 2003;86:151–6.
World Health Organization. International Classification of Functioning, Disability and Health. Geneva: World Health Organization, 2001.
Marcove RC, Miller TR, Cahan WC. The treatment of primary and metastatic bone tumors by repetitive freezing. Bull N Y Acad Med. 1968;44:532–44.
Marcove RC, Miller TR. Treatment of primary and metastatic bone tumors by cryosurgery. JAMA. 1969;207:1890–4.
Cahan WG, Woodard HQ, et al. Sarcoma arising in irradiated bone: report of 11 cases. Cancer. 1948;1:3–29.
Acknowledgment
This study was funded in part by the United States of America State Department Fulbright Scholarship Program (S.D.) and the Major Family Fund for Musculoskeletal Oncology (J.H.). The authors acknowledge Andrew G. Huvos, MD (1934–2006), who diagnosed most of these cases and educated a generation of pathologists and orthopaedic surgeons.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Domovitov, S.V., Healey, J.H. Primary Malignant Giant-Cell Tumor of Bone Has High Survival Rate. Ann Surg Oncol 17, 694–701 (2010). https://doi.org/10.1245/s10434-009-0803-z
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-009-0803-z